İskemik İnme Hastalarımızda Sigara ve Maraş Otu Kullanımı

Purpose: The aim of this study was to determine the frequency of maras powder use and cigarette smoking amongst stroke patients in our region. Patients and Methods: In this prospective study, evaluation was made of 200 patients who had been diagnosed with stroke and were being followed up in the Neurology Polyclinic of Kahramanmaras Sutcu Imam University between December 2017 and March 2018. A record was made for each case of age, sex, personal history, family history, and risk factors coronary artery disease, diabetes mellitus, hypertension, atrial fibrillation, hyperlipidemia, smoking status, use of maras powder and alcohol consumption . Neurological and physical examinations were performed. The findings of routine haematological and biochemical tests, carotidvertebral doppler ultrasonography, brain computed tomography and cranial magnetic resonance imaging were recorded. Results: A total of 200 patients were evaluated, comprising 121 60.5% males and 79 39.5% females with a mean age of 65.2±13 years. Risk factors were determined as hypertension in 146 73% patients, hyperlipidemia in 86 43% , diabetes mellitus in 61 31% , atrial fibrillation in 44 22% , coronary artery disease in 105 53% , cigarette smoking in 47 24% , maras powder use in 34 17% and alcohol consumption in 7 4% . Employing the Oxfordshire Community Stroke Project OCSP classification, the clinical syndrome was determined as total anterior circulation infarct in 4% of the patients, posterior circulation infarct in 21.5%, partial anterior circulation infarct in 43% and lacunar syndrome in 31.5%. Conclusion: Cigarette smoking and the use of smokeless tobacco are the most important modifiable risk factors for stroke. The effect on stroke of cigarette smoking and the use of smokeless tobacco must be kept in mind, and public awareness and education on this topic be undertaken. Lifestyle changes to protect against stroke should be advised.